Blog
RSS FeedPosted by Michael Wonder on 24 Mar 2019
Drug prices on TV? They may be coming.
23 March 2019 - The Trump administration is moving ahead with its proposal to require drug companies to disclose the ...
Posted by Michael Wonder on 23 Mar 2019
Drug company protections are latest stumbling block for NAFTA rewrite
21 March 2019 - President Trump’s ability to get his revised North American Free Trade Agreement through Congress may hinge ...
Posted by Michael Wonder on 14 Mar 2019
How Eli Lilly’s new generic insulin could impact prices across the market
14 March 2019 - The list price is $137.35 per vial. ...
Posted by Michael Wonder on 04 Mar 2019
Eli Lilly rolling out half-price insulin. Diabetics say it's not enough.
4 March 2019 - Eli Lilly said it plans to roll out a half-price version of its Humalog insulin, an ...
Posted by Michael Wonder on 28 Feb 2019
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug
28 February 2019 - U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, ...
Posted by Michael Wonder on 26 Feb 2019
'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA chief says
26 February 2019 - "The sick people are helping to subsidise the healthy people. That's not how insurance is supposed to ...
Posted by Michael Wonder on 25 Feb 2019
Roche has a $5 billion chance to lead on drug prices
25 February 2019 - A deal for gene-therapy developer Spark could help reset what’s now an exorbitant corner of the market. ...
Posted by Michael Wonder on 21 Feb 2019
Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke
22 February 2019 - Catalyst Pharmaceuticals rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its ...
Posted by Michael Wonder on 13 Feb 2019
Mylan launches Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder), at a list price 70% less than the brand
12 February 2019 - Unique pricing of Wixela Inhub immediately benefits patients and reduces overall cost to the U.S. health care ...
Posted by Michael Wonder on 12 Feb 2019
Catalyst Pharma sees net price of drug, once free, topping $300,000
12 February 2019 - Catalyst Pharmaceuticals said on Monday that it expects its drug for a rare disease, which had ...
Posted by Michael Wonder on 11 Feb 2019
‘One-and-done’ for new drugs could cut patent thickets and boost generic competition
11 February 2019 - In a perfect world, the system for conveying medications from their makers to patients should be ...
Posted by Michael Wonder on 11 Feb 2019
Regeneron and Sanofi offer Praluent (alirocumab) at a new reduced U.S. list price
11 February 2019 - This is the latest step by the companies to help make Praluent more accessible and affordable for ...
Posted by Michael Wonder on 08 Feb 2019
J&J becomes first drug maker to add prices to television ads
8 February 2019 - Johnson & Johnson said on Thursday it will start adding the price of its medicines to ...
Posted by Michael Wonder on 04 Feb 2019
This once free drug for a rare condition now costs $375,000
4 February 2019 - Firdapse, a drug used for treatment of a rare neurological disorder that affects one in 100,000 ...
Posted by Michael Wonder on 29 Jan 2019
America’s love affair with cheap drugs has a hidden cost
29 January 2019 - Data, documents and interviews show how a focus on cutting prices has come with risks to consumer ...